Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 조수경 | - |
dc.date.accessioned | 2018-03-11T03:41:23Z | - |
dc.date.available | 2018-03-11T03:41:23Z | - |
dc.date.issued | 2013-02 | - |
dc.identifier.citation | Seminars in arthritis and rheumatism, 42, 4, 424 - 432 | en_US |
dc.identifier.issn | 0049-0172 | - |
dc.identifier.uri | http://www.semarthritisrheumatism.com/article/S0049-0172(12)00171-0/fulltext | - |
dc.identifier.uri | http://hdl.handle.net/20.500.11754/44912 | - |
dc.description.abstract | Objectives: To estimate the positivity and agreement between QuantiFERON-tuberculosis (TB) gold in tube test (QFT-GIT) and tuberculin skin test (TST) according to underlying rheumatic diseases and to identify the influencing factors on discrepancies between the 2 tests.Methods: Among the 757 patients who underwent both QFT-GIT and TST simultaneously from September 2008 to November 2010, patients with indeterminate QFT-GIT results (n = 21), with active (n = 11) or suspicious (n = 1) findings for tuberculosis on a chest radiograph, were excluded. Finally, 724 patients were recruited for this study: 497 patients with rheumatoid arthritis (RA), 198 with ankylosing spondylitis (AS), and 29 with juvenile rheumatoid arthritis (JRA). The agreement between the 2 tests was estimated by Cohen's kappa and factors influencing discrepancies were identified using multivariate analysis.Results: The positivity of QFT-GIT was higher in RA than AS or JRA (30.2%, 16.2%, and 3.4%, respectively). In contrast, TST positivity was highest in AS compared to RA and JRA (45.5%, 28.2%, and 17.2%, respectively). The agreement between the 2 tests was low in all patients (kappa = 0.285). The only predictor of a discrepancy between the 2 tests was older age. Factors associated with discordant QFT-GIT-negative/TST-positive results were female [odds ratio (OR) = 2.33, confidence interval (CI) 1.11 to 4.89] and AS (OR = 3.12, CI 1.44 to 6.79), whereas a discordant QFT-GIT-positive/TST-negative result was associated with glucocorticoid use (OR = 2.44, CI 1.24 to 4.81).Conclusions: The agreement between the 2 tests is low; therefore, it would be better to perform both tests than to use any 1 test alone for the detection of LTBI in TB-endemic regions. Female and underlying AS are related to being QFT-GIT-negative/TST-positive, and the use of glucocorticoid is associated with being QFT-GIT-positive/TST-negative. (c) 2013 Elsevier Inc. All rights reserved. Semin Arthritis Rheum 42:424-432 | en_US |
dc.description.sponsorship | This study was supported by the research fund of Hanyang University (HY-2009-000-0000-0969). | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier Science B.V., Amsterdam | en_US |
dc.subject | QuantiFERON-TB gold in tube test | en_US |
dc.subject | tuberculin skin test | en_US |
dc.subject | latent tuberculosis infection | en_US |
dc.subject | tumor necrosis factor inhibitor | en_US |
dc.subject | rheumatic disease | en_US |
dc.title | Factors Influencing Discrepancies Between the QuantiFERON-TB Gold in Tube Test and the Tuberculin Skin Test in Korean Patients with Rheumatic Diseases | en_US |
dc.type | Article | en_US |
dc.relation.volume | 42 | - |
dc.identifier.doi | 10.1016/j.semarthrit.2012.07.001 | - |
dc.relation.page | 424-432 | - |
dc.relation.journal | SEMINARS IN ARTHRITIS AND RHEUMATISM | - |
dc.contributor.googleauthor | Kim, J. H. | - |
dc.contributor.googleauthor | Cho, S. K. | - |
dc.contributor.googleauthor | Han, M. | - |
dc.contributor.googleauthor | Choi, C. B. | - |
dc.contributor.googleauthor | Kim, T. H. | - |
dc.contributor.googleauthor | Jun, J. B. | - |
dc.contributor.googleauthor | Bae, S. C. | - |
dc.contributor.googleauthor | Yoo, D. H. | - |
dc.contributor.googleauthor | Sung, Y. K. | - |
dc.relation.code | 2013012007 | - |
dc.sector.campus | S | - |
dc.sector.daehak | COLLEGE OF MEDICINE[S] | - |
dc.sector.department | DEPARTMENT OF MEDICINE | - |
dc.identifier.pid | skchomd | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.